In Brief:
- Using an imaging technique to visualize pain signals in facial nerves, NIDCR researchers identified a protein that enhances neurons’ responses to painful stimuli.
- Blocking the protein in mice blunted pain signaling; the results could inform the development of safer, non-opioid pain therapies.
NIDCR researchers recently caught facial nerves on camera responding in real-time to pain signals. Their work uncovered a key role for a protein called cyclin-dependent kinase 5 (Cdk5) in pain signaling. The collaboration between scientists in the labs of Ashok Kulkarni, PhD, and Ken Yamada, MD, PhD, showed that blocking Cdk5 blunted the activity of pain-sensing neurons. Kulkarni and Yamada credited their co-mentee, first author, and NIDCR research fellow Minghan Hu, PhD, for bridging the two labs’ distinct expertise for the study. The findings could provide insight into ways to develop safer, non-opioid treatments for orofacial pain.